[Featured Stock] Celltrion Healthcare Surges Over 9% on Earnings Expectations
On the 12th, Celltrion Healthcare showed strong performance.
As of 10:32 AM on the same day, Celltrion Healthcare's stock price was trading at 73,200 KRW, up 9.42% compared to the previous trading day.
Celltrion Healthcare is expected to have recorded operating revenue of 61.8 billion KRW in the first quarter, an increase of about 37% compared to the same period last year.
Hot Picks Today
"Who Would Buy an 'Ugly' Car?" Despite Harsh Reviews, All $920,000 Ferraris Already Sold Out
- "Down 17% — 'This Is Too Much'... Frustrated Shareholders Enter Politics Themselves"
- "Betrayal in a Cup of Iced Coffee"... Even 7,500 Won Coffee Not Spared from 'Contaminated Ice'
- "My Money Is Melting Away... Government Blamed for Turning Stock Market Into a Playground for Foreign Investors Amid Market Crash"
- "Licking a Straw Changed His Life: The Consequence for a 19-Year-Old's Vending Machine Prank"
Jae-kyung Park, a researcher at Hana Securities, stated, "It is difficult to confirm an improvement in Celltrion Healthcare's profitability in 2023," but added, "Attention should be paid to events driving 2024 performance, such as the FDA approval of Uplima starting in the second quarter, the launch of Uplima in the U.S. in the second half of this year, and its listing on major PBM prescription formularies."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
